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Abstract: In the present study we aimed to perform the first analysis of antimicrobial activity of bacteria 
isolated from Krubera-Voronja Cave, with the main focus on their activity against Gram-
positive bacteria, including Gram-positive pathogens. Using five different media, in total 
874 heterotrophic cultures were isolated from water and sediment samples collected in 
Krubera-Voronja Cave at a depth from 220 m to 1640 m. 14.0% of all isolates demonstrated 
antibacterial activity against Gram-positive and Gram-negative test microorganisms. Our 
results show that this percentage was not uniform; it increased with the sampling depth and 
was the highest in the lower part of the cave. 24 isolates were active exclusively against 
Gram-positive test strains Micrococcus luteus and Bacillus thuringiensis. Two isolates, 
namely strains 1350R2-TSA30-6 and 1410WF1-TSA30-2, were chosen for the further work 
because of the high and comparable activity against both Gram-positive test microorganisms. 
It was determined that both strains belong to the family Bacillaceae in phylum Firmicutes. The 
detailed bioactivity analysis of these two Gram-positive strains revealed the different mixtures 
of volatile compounds with antibacterial activity. The main antibacterial compounds of the 
strain 1350R2-TSA30-6 are pyrrolopyrazines pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-
3-(2-methylpropyl)- and pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(phenylmethyl)-. The 
main antibacterial compound of the strain 1410WF1-TSA30-2 is 1,2-benzenedicarboxylic 
acid, bis(2-methylpropyl) ester. Mixtures of the volatile antimicrobial compounds of both 
strains were antagonistic against Gram-positive strains isolated from Krubera-Voronja Cave, 
and their activity against Gram-positive pathogenic bacteria substantially differed. 
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INTRODUCTION
Antibiotic resistance of pathogenic bacteria became 
one of the greatest threats to human health over the 
last few decades (Blair et al., 2015). A few different 
approaches are used to resolve this problem: chemical 
synthesis of novel antibiotics (Wright et al., 2014), 
discovery and development of novel agents capable of 
circumventing or neutralizing the existing resistance 
mechanisms (Blair et al., 2015), as well as search for 
new natural antimicrobials (Lamprinou et al., 2015). 
Considering the last-mentioned approach, caves 
represent one of the most attractive environments 
with a strong potential for the discovery of novel 
antimicrobials. Antimicrobial activity of different 
cave microorganisms against pathogenic bacteria 
was reported previously (Herold et al., 2005; Nakaew 
et al., 2009; Rajput et al., 2012; Cheeptham et al., 
2013; Rule & Cheeptham, 2013; Tomova et al., 2013; 
Lamprinou et al., 2015); a new genus of bacteria, 
producing antimicrobial substances, was identified in 
a cave in Thailand (Nakaew et al., 2012). 
Ecological conditions enabling cave microorganisms 
to produce antimicrobial compounds are unclear. 
Montano & Henderson (2013) showed that the 
frequency of human visitation does not affect the 
antimicrobial activity of cave microorganisms, while 
the increasing depth, and consequently increasing 
oligotrophy do. Energy-starved conditions in the 
caves prompt the complex interactions (competitive 
or cooperative) between different microorganisms 
resulting in the production of secondary metabolites, 
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such as pigments, siderophores, and antibiotics, 
which are used as informational cues (Rajput et al., 
2012; Gabriel & Northup, 2013). Krubera-Voronja 
Cave is the Earth’s deepest cave (Sendra & Reboleira, 
2012). Because of its depth, high antimicrobial activity 
of microorganisms living in it could be expected, but it 
has not been investigated so far. 
Antimicrobial potential of cave actinobacteria and 
especially Streptomyces was investigated (Herold 
et al., 2005; Nakaew et al., 2009; Hodges et al., 
2012; Rajput et al., 2012; Cheeptham et al., 2013; 
Rule & Cheeptham, 2013; Nimaichand et al., 2015), 
but the antimicrobial compounds of bacteria from 
other phyla – Cyanobacteria (Lamprinou et al., 
2015), Proteobacteria and Bacteroidetes (Tomova 
et al., 2013) – were also of scientific interest. Our 
previous cultivation-independent analysis of bacterial 
diversity in Krubera-Voronja Cave showed that 
Gram-positive phyla Actinobacteria and Firmicutes 
were among the most numerous phyla in this cave 
(Kieraite-Aleksandrova et al., 2015). This indicates 
during the evolution the indigenous Gram-positive 
bacteria of Krubera-Voronja Cave could have evolved 
the mechanisms to compete and/or collaborate 
specifically with other Gram-positive bacteria. The 
production of antimicrobial compounds could be 
regarded as one of those mechanisms. Antimicrobial 
activity of the indigenous Gram-positive bacteria of 
Krubera-Voronja Cave against other Gram-positive 
bacteria is still unknown and should be evaluated, 
the rather that the search for novel antimicrobials 
targeting Gram-positive pathogens is of major 
importance. These bacteria most commonly cause 
severe nosocomial infections, and the resistance of 
these pathogens to conventionally used antimicrobials 
continuously increases and strengthens (Herold et 
al., 2005). Therefore, screening for novel narrow-
spectrum antimicrobials, that would be active against 
Gram-positive pathogens, is vital. 
In the present study we aimed to perform the first 
analysis of antibacterial activity of microorganisms 
isolated from Krubera-Voronja Cave, mainly focusing 
on their activity against Gram-positive bacteria 
including Gram-positive pathogens. 
MATERIAL AND METHODS
Site description and sampling
Krubera-Voronja Cave is located in the Arabica 
Massif (43.4184 N 40.3083 E, Western Caucasus). 
Sampling in Krubera-Voronja Cave was described 
explicitly in our previous work (Kieraite-Aleksandrova 
et al., 2015). It was performed on 30th July to 7th 
August 2012, at depths of 220 m to 1640 m. At the 
time of sampling, humidity ranged from 69-76% in 
the upper part (220-230 m in depth) of the cave to 
>90% in the middle (500-700 m in depth) and the 
lower (1215-1640 m in depth) parts of the cave. The 
temperature in the cave ranged from 3-4°C in the 
upper and middle parts to 6-8°C in the lower part 
of the cave. 
In total, 26 samples were collected from Krubera-
Voronja Cave. The collected sample materials 
included soil and clay from cave walls, sediment, 
speleothems, drinkable water from the underground 
camps as well as coloured spots from cave walls. All 
samples were collected using aseptic techniques and 
placed into sterile microcentrifuge tubes. The samples 
were transported in a cooler and stored at -20°C until 
microbial analysis was performed. 
Isolation of bacterial cultures 
For isolation of culturable microorganisms 
from water samples, 100 μL of each sample was 
spread over different solid microbiological media 
dispensed in Petri dishes. For isolation of culturable 
microorganisms from sediment samples, 300 mg 
of each sample was suspended in 700 μL of saline, 
and 100 μL of each suspension was spread over 
different solid microbiological media. Tryptic Soy 
agar (TSA) (Merck Millipore), Hickey-Tresner (HT) 
agar, Actinomycetes Isolation (AI) agar, Starch Casein 
Nitrate agar (SCNA), and Difco™ ISP medium 4 (ISP4) 
were used. The cultivation media were selected 
according to Cheeptham et al. (2013) and Hodges 
et al. (2012) as well as the previous data on the 
bacterial diversity in Krubera-Voronja Cave (Kieraite-
Aleksandrova et al., 2015). It was previously shown 
that Actinobacteria, Firmicutes, and Proteobacteria 
were the dominant phyla in this cave. HT agar, AI 
agar, SCNA and ISP4 are usually used for the isolation 
and cultivation of Actinobacteria, and TSA is routinely 
used for the isolation and cultivation of Firmicutes 
and Proteobacteria. Two different temperatures were 
chosen for the isolation of microorganisms from 
the cave samples: 4°C and 30°C. The first one was 
selected according to the temperature profile inside 
the cave (3-8°C, see above); it is suitable for the 
growth of psychrophiles that were believed to thrive 
in the cave. The second temperature is suitable for 
the growth of psychrotolerant microorganisms that 
have an optimum temperature between 20°C and 
40°C, but could be metabolically active at the cave’s 
temperature. Microorganisms were cultivated at 
4°C for 7 days and at 30°C for 3 days. Only those 
microorganisms that stood apart in colony morphology 
and in ability to excrete soluble pigments were chosen 
for further work.
Primary screening of microbial isolates for 
antibacterial activity
In order to identify microbial isolates with 
antibacterial activity, a modified version of agar 
diffusion test (cross-streak assay) was used (Montano 
& Henderson, 2013). Cave microorganisms were 
streaked and cultivated under the same conditions 
and on the same solid medium which they were 
isolated. For example, bacterial cultures 1350R2-
TSA30-6 and 1410WF1-TSA30-2 were initially isolated 
on TSA at 30°C. Therefore, for the primary screening 
for antibacterial activity, they were restreaked on TSA 
and cultivated at 30°C. For screening, the plates with 
the streaks of the cave microorganisms were covered 
with a layer of sterile TSA. Test microorganisms were 
streaked on sterile TSA perpendicularly to the already 
grown streaks of the cave microorganisms. Test 
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microorganisms were cultivated at 30°C for 24 h. The 
zone of growth inhibition of the test microorganisms 
near the cave isolate streak indicated antimicrobial 
activity of the cave microorganisms. No inhibition 
was defined as absent interruption of the target test 
microorganism streak where it crossed the cave isolate 
streak. Gram-positive (Micrococcus luteus and Bacillus 
thuringiensis TL8) and Gram-negative (Escherichia 
coli BL21(DE3) and Pseudomonas sp. VR1) bacteria 
served as test microorganisms. 
Genotyping of the active isolates
The bacterial genomic DNA was extracted from 
fresh cell culture using the GeneJET™ Genomic DNA 
Purification Kit (Thermo Fisher Scientific) according 
to the manufacturer’s instructions. BOX-PCR was 
performed in 50 μL of reaction mixture containing 
DreamTaq Green PCR Master Mix (2X) (Thermo Fisher 
Scientific), 0.5 μM BOXA1R primer (5’-CTA CGG CAA 
GGC GAC GCT GAC G-3’) and 10 ng of bacterial 
genomic DNA. BOX-PCR was conducted under the 
following conditions: initial denaturation at 95°C for 
2 min followed by 29 cycles, each consisting of 95°C 
for 1 min, 53°C for 2 min, and 72°C for 3 min with 
a final extension step at 72°C for 7 min. Products 
of amplification were analysed by electrophoresis 
through 1% agarose gel.
Phylogenetic analysis of active isolates
Amplification of 16S rRNA genes was done according 
to Kuisiene et al. (2002). PCR products were cloned 
into E. coli DH5α using the CloneJET™ PCR Cloning 
Kit (Thermo Fisher Scientific). Recombinant plasmids 
were isolated using the GeneJET™ Plasmid Miniprep 
Kit (Thermo Fisher Scientific). 16S rRNA genes of 
strains 1350R2-TSA30-6 and 1410WF1-TSA30-2 were 
sequenced at the DNA Sequencing Centre (Vilnius 
University, Institute of Biotechnology, Lithuania); 
the obtained sequences were edited and sequence 
similarity was determined using the SEQBUILDER 
and MEGALIGN components of LASERGENE 6 
(DNASTAR). 16S rRNA gene sequences were subjected 
to phylogenetic analysis using ARB (Ludwig et al., 
2004). The size of the 16S rRNA gene used for the 
analysis was 1372 nt. The tree was rooted using the 
16S rRNA gene sequence of Paenibacillus polymyxa 
DSM 36T as an outgroup. 
Nucleotide sequence accession numbers
16S rRNA gene sequences of strains 1350R2-
TSA30-6 and 1410WF1-TSA30-2 were deposited in 
the GenBank under the No. KU513788 and KU513789 
respectively. 
Evaluation of antimicrobial activity of active 
isolates by agar-well diffusion method
Test microorganisms were cultivated on TSA medium 
at 30°C for 24 h and then resuspended in saline. The 
correlation between the optical density of bacterial 
suspensions at 600 nm and the number of CFU/mL 
after the TSA plate counts was established for test 
microorganisms. For the evaluation of antimicrobial 
activity, the suspension of the test microorganism 
was mixed with molten TSA to achieve final 106 CFU/
mL. Inoculated TSA was poured into the Petri dishes 
(20 mL per dish). 5 mm diameter wells were cut in 
the inoculated agar surface and filled with 100 μL 
of the sample. The zone of the growth inhibition of 
test microorganisms indicated antimicrobial activity 
of the sample and was recorded as a zone diameter 
(in millimeters) around the wells, minus 5-mm 
diameter of the well (Choma & Grzelak, 2011; Tomova 
et al., 2013).
Optimization of culture growth parameters for 
production of antibacterial compounds
Effects of the concentration of nutrients, growth 
medium pH, temperature and aeration on the 
culture growth were examined in order to optimize 
the production of antibacterial compounds. Effects 
of the concentration of nutrients were examined 
using 1xTryptic Soy broth (TSB), 0.5xTSB and highly 
nutritious growth medium Brain Heart Infusion broth 
(BHIB). To test the effect of pH, growth medium was 
prepared in 50 mM Tris-HCl buffer (pH 7, 8, and 
9/20°C). For determination of the effect of temperature, 
30°C (the isolation temperature), 16°C, 8°C (the upper 
temperature limit of the cave), and 4°C (the lower 
temperature limit of the cave) were chosen. The effect 
of aeration was determined at 180 rpm and 250 rpm 
in an orbital shaker Multitron Standard (INFORS HT). 
Inoculation (5% vol/vol) was performed using 
bacterial cultures grown for 12 h on TSA plates at 
30°C. Inocula were prepared in the respective sterile 
growth medium. Bacteria were cultivated in 250 mL 
Erlenmeyer flasks, and the samples were aseptically 
removed every 2 h to determine culture growth and 
production of antimicrobial compounds. Growth of the 
culture was monitored by measuring optical density 
at 600 nm, and antimicrobial activity of the culture 
was assayed in the culture supernatant by agar-well 
diffusion method (see above). Cells from the liquid 
culture were removed by centrifugation (7000×g, 20 
min, 4°C). 
Extraction of antibacterial compounds by salting-
out with ammonium sulphate
Active bacterial strains were cultivated in buffered 
0.5xTSB for 12 h at 30°C at 180 rpm in the orbital 
shaker Multitron Standard (INFORS HT). Cells 
were removed by centrifugation (7000×g, 20 min, 
4°C), and solid ammonium sulphate was added to 
the supernatant to achieve 80% saturation. The 
precipitate was recovered by centrifugation (12000×g, 
20 min, 4°C), then dissolved in 20 mM Tris-HCl 
buffer (pH 7). The dissolved proteins were evaluated 
for the antimicrobial activity using agar-well 
diffusion method. The dissolved proteins were also 
treated with recombinant proteinase K (Thermo 
Fisher Scientific) according to the manufacturer’s 
instructions. Antimicrobial activity of hydrolysed 
proteins was also evaluated using agar-well diffusion 
method. Protein concentration was determined 
using the Pierce™ Coomassie (Bradford) Protein 
Assay Kit (Thermo Fisher Scientific) according to the 
manufacturer’s instructions. 
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Extraction of antibacterial compounds by organic 
solvents
Active strains were cultivated in 100 mL of buffered 
0.5xTSB for 12 h at 30°C at 180 rpm in the orbital 
shaker Multitron Standard (INFORS HT). Cells were 
removed by centrifugation (7000×g, 20 min, 4°C). 
Antibacterial compounds in the supernatant were 
extracted with equal volume of acetone, chloroform, 
ethyl acetate, methanol, and hexane in a separating 
funnel. Different supernatant samples of the same 
culture were separately extracted with each solvent. 
The organic solvent extracts were evaporated to 
dryness and dissolved in chloroform (Sanghvi et al., 
2014). 
Thin layer chromatography and bioautography
Thin layer chromatography (TLC) of chloroform 
extract was done on Silica gel 60 F254 plates (Merck 
Millipore). The antibacterial compounds were 
separated with ethyl acetate-methanol (3:1, vol/vol) 
solvent system. Chromatograms were observed under 
UV light and exposed to iodine vapours. Bioautography 
was used for the localization of antibacterial 
compounds in chloroform extract (Attimarad et al., 
2012). TLC plate with the separated antibacterial 
compounds was dried, put in sterile Petri dish, and 
overlaid with the inoculated TSA. Inoculated TSA was 
prepared as described above for the agar well diffusion 
method. M. luteus was used for bioautography as the 
test microorganism. After incubation at 30°C for 24 h, 
the zone of inhibition around the spot of antibacterial 
compound was determined. The fractions with 
antibacterial activity were recovered from TLC plates, 
disssolved in ethyl acetate and subjected to further 
analysis. 
Gas chromatography-mass spectrometry (GC-MS) 
analysis of antibacterial compounds
Gas chromatographic (GC) analysis of the fractions 
with antibacterial activity recovered from TLC plates 
was performed on a PerkinElmer Clarus 580 series gas 
chromatograph coupled to a PerkinElmer Clarus 560 
S mass spectrometer (PerkinElmer, Shelton, USA). 
The GC system was equipped with Elite-5MS capillary 
column (30 m × 0.25 mm id, 0.25 µm film thickness) 
coated with methylpolysiloxane (5% phenyl). Helium 
was employed as a carrier gas with a constant flow of 
1 mL/min. GC conditions were as follows: the oven 
temperature was programmed: 40°C for 1 min, from 
40 to 250°C at 3°C/min and held at 250°C for 8 min; 
the injector temperature was held at 250°C. Injection 
was performed in pulsed splitless mode (pulsed to 4 
mL/min until 1.5 min, split (10:1) open at 1.55 min). 
The capillary column was connected to the ion source 
of the mass spectrometer by means of the transfer 
line maintained at 280°C. The electron ionization ion 
source conditions were: electron energy 70 eV and 
temperature 180°C. GC-MS in full scan mode was 
used. The analyses were carried out with a filament 
multiplier delay of 3 min, and the acquisition was 
performed in the range of m/z 33 - 600. The qualitative 
identification of different compounds was performed 
by comparing their mass spectra with those stored 
in the NIST (The National Institute of Standards and 
Technology) library. The relative amounts of individual 
compounds were expressed as percentages of the peak 
area relative to the total peak area. GC-MS identified 
compounds were compared with the bacterial organic 
volatile compounds included in the Microbial Volatile 
Organic Compounds (mVOC) database (Lemfack et 
al., 2014) as well as with those in the SuperScent 
database (Dunkel et al., 2009). 
Evaluation of antibacterial activity against 
pathogens and microorganisms of the cave
For evaluation of antibacterial activity against 
pathogens and microorganisms of the cave, the active 
fractions, recovered from TLC plates and dissolved in 
ethyl acetate, were used.
Antibacterial activity was determined against 
Gram-positive pathogenic bacteria: Bacillus cereus 
ATCC 10876 (Firmicutes), Enterococcus faecalis ATCC 
29212 (Firmicutes), Listeria monocytogenes ATCC 
7644 (Firmicutes), Staphylococcus aureus subsp. 
aureus ATCC 25923 (Firmicutes), and Rhodococcus 
equi ATCC 6939 (Actinobacteria). Agar-well diffusion 
method was used for determination of the minimal 
inhibitory concentration (MIC). The inocula of the 
pathogenic bacteria were prepared in saline and 
matched 0.5 McFarland standard. 19 mL of melted 
and cooled down TSA medium was inoculated with 
1 mL of such suspension and poured into Petri dish. 
The final concentration of cells in TSA was 106 CFU/
mL. 5 mm diameter wells were cut in the inoculated 
agar surface and filled with 100 μL of the sample. Six 
different concentrations of antimicrobial compounds 
were used for determination of MIC: 4.66 mg/mL (the 
undiluted sample), 2.33 mg/mL (1:1 dilution), 1.165 
mg/mL (1:3 dilution), 582.5 μg/mL (1:7 dilution), 
291.25 μg/mL (1:15 dilution), and 145.625 μg/mL 
(1:31 dilution). 
In the current work antibacterial activity of the active 
fractions was also examined against bacteria isolated 
from Krubera-Voronja Cave: Gram-positive strain 
28TSA30-8, Brevibacillus sp. 1410WF1-HT30-5, 
Paenibacillus sp. 23TSA30-6, Paenibacillus sp. 
28ISP30-5, and Streptomyces sp. 1350R2-SCNA30. 
Modified agar-well diffusion method was used for this 
test. Sterile TSA (20 mL) was poured into the Petri 
dish, and the well was cut in agar in the centre of the 
Petri dish. Bacterial cultures were streaked from the 
edge of the well to the border of the Petri dish. Then the 
well was filled with 100 μL of the sample containing 
antimicrobial compounds at a concentration of 1.165 
mg/mL. Growth inhibition indicated the antibacterial 
activity of the tested compounds. 
RESULTS
Isolation and antibacterial activity of microorganisms 
from samples of Krubera-Voronja Cave
In total, 874 heterotrophic cultures were isolated 
using five different media: TSA, HT agar, AI agar, 
SCNA, and ISP4. 108 isolates were from water 
samples, and 766 – from sediment samples collected 
in Krubera-Voronja Cave at the depth from 220 m 
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to 1640 m (Kieraite-Aleksandrova et al., 2015). The 
largest number of cultures was isolated on TSA (93 
isolates at 4°C and 141 - at 30°C) and HT agar (207 
isolates at 30°C). The smallest number of isolates 
was obtained using AI agar – 138 at 30°C. In general, 
temperature of 30°C was more suitable for the growth 
of heterotrophs – 714 cultures were obtained at this 
temperature, while only 160 cultures – at 4°C. Only 
TSA and ISP4 were suitable for growth at the latter 
temperature. 
In order to examine antibacterial activity of the 
isolated cultures, primary screening using agar 
diffusion test was performed. Out of 874 cultures, 122 
isolates (14.0%) demonstrated antibacterial activity. 
108 active isolates were obtained from sediment 
samples, and 14 – from water samples. Most (63.9%) 
of the active isolates inhibited growth of a single test 
microorganism, while four isolates possessed a broad 
activity spectrum, being antagonistic against all test 
microorganisms. Only 9.3% of isolates from the upper 
part of the cave (sampling at 220-230 m in depth) 
showed antimicrobial activity, while 11.1% and 14.1% 
of all isolates from the middle (sampling at 500-700 
m in depth) and lower (sampling at 1215-1640 m in 
depth) parts of Krubera-Voronja Cave, respectively, 
inhibited growth of at least one test strain. 
Our previous cultivation-independent analysis 
showed that Gram-positive phyla Actinobacteria and 
Firmicutes were among the dominant phyla in Krubera-
Voronja Cave (Kieraite-Aleksandrova et al., 2015). 
Therefore, we particularly focused on the isolates 
that exhibited antagonism only against Gram-positive 
but not against Gram-negative test microorganisms. 
In total, 31 isolates inhibited growth of two different 
test strains, and 24 of them were active only against 
Gram-positive ones. Activity of most of these 24 
isolates against both Gram-positive test strains was 
very weak; somewhat stronger activity was observed 
only for seven cave isolates. Two cave isolates, 
1350R2-TSA30-6 and 1410WF1-TSA30-2, were 
chosen for further experiments because of their high 
and comparable activity against both Gram-positive 
test strains – M. luteus from phylum Actinobacteria 
and B. thuringiensis TL8 from phylum Firmicutes. 
Both 1350R2-TSA30-6 and 1410WF1-TSA30-2 were 
isolated on TSA at 30°C from samples 1350R2 and 
1410WF1 that have been collected in the lower part 
(1350 m and 1410 m depth) of Krubera-Voronja Cave. 
Sample 1350R2 was the sample of white clay from the 
rarely visited branch of the cave, and sample 1410WF1 
was the sample of water from the underground camp 
(Kieraite-Aleksandrova et al., 2015).
Genotyping and phylogenetic analysis  
of active isolates
In order to determine whether isolates 1350R2-
TSA30-6 and 1410WF1-TSA30-2 represent two 
different strains, BOX-PCR genotyping was performed. 
Our analysis clearly showed that these two isolates 
belong to two different strains (Fig. 1). 
16S rRNA genes of these two strains were cloned, 
sequenced and analysed. The BLAST search showed 
that both strains belong to the family Bacillaceae 
in phylum Firmicutes. Both strains were assigned 
to the genus Bacillus (Fig. 2). 16S rRNA gene of the 
strain 1410WF1-TSA30-2 was most similar to those 
of Bacillus aerophilus, Bacillus altitudinis and Bacillus 
stratosphericus with 99.9% sequence similarity. 
Strain 1350R2-TSA30-6 clustered with Bacillus 
simplex, Bacillus frigoritolerans and Bacillus muralis 
with 99.8%, 99.6% and 99.5% sequence similarity 
respectively. 
The effect of culture growth parameters for the 
production of antibacterial compounds
Optimization experiments showed that growth 
of a culture as well as production of antibacterial 
compounds depended on the concentration of 
nutrients in a culture medium. For the strain 1350R2-
TSA30-6, the highest optical density (OD600) as well 
as the largest antimicrobial activity were observed in 
0.5xTSB (data for BHIB not shown) (Fig. 3). For the 
strain 1410WF1-TSA30-2, similar maximum OD600 
and antibacterial activity were obtained in TSB and 
0.5xTSB, but the growth rate was higher in 0.5xTSB 
(Fig. 3). BHIB was the worst choice for the strain 
1410WF1-TSA30-2 in terms of both culture growth 
and antibacterial activity (data not shown). Therefore, 
for both strains further optimization experiments 
were carried out in 0.5xTSB. 
Fig. 1. BOX-PCR electrophoretic profiles. M - GeneRuler 
1 kb DNA Ladder (Thermo Fisher Scientific); 1 - 1350R2-
TSA30-6; 2 - 1410WF1-TSA30-2. The results of this test 
indicate that isolates 1350R2-TSA30-6 and 1410WF1-
TSA30-2 are distinct.
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Both the growth of a culture and the production of 
antibacterial compounds were influenced by pH of a 
culture medium. The best pH for the strain 1350R2-
TSA30-6 was pH 7, and for the strain 1410WF1-TSA30-2 
it was pH 9. Aeration did not influence the results of our 
experiments; highly similar results were obtained for 
both 180 rpm and 250 rpm. Low (16°C) temperature was 
not suitable for the growth of both strains – the strain 
1410WF1-TSA30-2 did not grow, and OD600 for the 
strain 1350R2-TSA30-6 at this temperature was ~3.3 
times lower than at 30°C. Consequently, the growth in 
the liquid culture at 8°C and 4°C was not tested. 
Based on these results, both strains were further 
cultivated in buffered 0.5xTSB at 30°C at 180 rpm. 
Fig. 2. Phylogenetic positions of strains 1350R2-TSA30-6 and 1410WF1-TSA30-2 as well as the nearest 
neighbors from the family Bacillaceae. The numbers at the nodes represent percent of bootstrap values 
obtained from 1000 samplings. Only the most significant values (higher than 70%) are presented. 
Paenibacillus polymyxa DSM 36T was defined as an outgroup of the tree. Scale bar, 0.01 nucleotide 
substitution per site.
pH of the medium was adjusted to 7 for cultivation of 
the strain 1350R2-TSA30-6 and to 9 for cultivation 
of the strain 1410WF1-TSA30-2. Growth curves and 
antimicrobial activity, obtained after the optimization 
experiments, are shown in Fig. 3. It is noteworthy 
that for both strains the production of antimicrobial 
compounds started in the exponential growth phase 
and continued during the growth of the culture.
Extraction of antimicrobial compounds
Two different approaches were used for the 
extraction of antimicrobial compounds from the 
culture supernatant – salting-out with ammonium 
sulphate and extraction by organic solvents. 
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Salted-out extracellular proteins of strains 1350R2-
TSA30-6 and 1410WF1-TSA30-2 showed antibacterial 
activity against M. luteus (data not shown). The 
treatment with proteinase K did not diminish this 
activity. These experiments allowed us to suggest that 
antimicrobial compounds produced by both strains 
are not peptides or proteins. 
Acetone, chloroform, ethyl acetate, methanol, and 
hexane were used separately for extraction of the 
different aqueous samples of the same culture by 
organic solvents. All extractions were successful; 
antibacterial activity was detected in all extracts for 
both strains. Antimicrobial activity of the extracts of 
the strain 1350R2-TSA30-6 was considerably higher 
than of the extracts of the strain 1410WF1-TSA30-2. 
It was detected that different extracts of the strain 
1410WF1-TSA30-2 exhibited comparable activity 
for all solvents used, while hexane and chloroform 
extracts were the most active in the case of strain 
1350R2-TSA30-6 (Table 1). So, chloroform extracts 
were used for characterization of antimicrobial 
compounds produced by both strains.
Strain Ethyl acetate Acetone Hexane Chloroform Methanol
1350R2-TSA30-6 1.5 3.0 4.0 3.5 2.0
1410WF1-TSA30-2 1.0 1.5 1.5 1.0 1.5
Table 1. Antimicrobial activity of organic solvents’ extracts. Micrococcus luteus was used as the test microorganism in this 
agar-well diffusion assay, the width of the inhibition zone is shown in millimeters.
Fig. 3. Optimization of the nutrient concentrations. Effect on the culture growth and 
production of antibacterial compounds is shown. The width of inhibition zones is 
expressed in millimeters and shown at the sampling points. “Optimal” is the growth 
curve and antimicrobial activity under optimal conditions: 0.5xTSB in 50 mM Tris-
HCl, pH 7, 30ºC, 180 rpm for strain 1350R2-TSA30-6 and 0.5xTSB in 50 mM Tris-
HCl, pH 9, 30ºC, 180 rpm for strain 1410WF1-TSA30-2. “0.5xTSB“ is the growth 
curve and antimicrobial activity under the following conditions: 0.5xTSB, pH 7 
(unbuffered medium), 30ºC, 250 rpm for both strains. “TSB“ is the growth curve 
and antimicrobial activity under the following conditions: 1xTSB, pH 7 (unbuffered 
medium), 30ºC, 250 rpm for both strains.
Characterization of antimicrobial 
compounds
Antimicrobial compounds of strains 
1350R2-TSA30-6 and 1410WF1-TSA30-2 
were analysed using TLC and bioautography. 
Both strains showed two different fractions 
on TLC plates, but only a single fraction of 
each strain showed antimicrobial activity 
against Gram-positive bacteria M. luteus 
(Fig. 4). Retardation factor (Rf) of the compounds 
with antimicrobial activity differed. Rf for the 
compound of the strain 1350R2-TSA30-6 was 
0.85, and for the strain 1410WF1-TSA30-2 it 
was 0.93. The active compounds were recovered 
from the TLC plates and analysed by GC-MS. 
GC-MS was used to determine a chemical 
composition of the two active TLC fractions. Main 
components of the active fraction of the strain 
1350R2-TSA30-6 were pyrrolizidines (Table 2, 
compounds No. 8-12). Their total amount was 
60.3%. For four peaks (RT 46.23, 49.58, 50.19, 
and 58.70 min, compounds No. 8-11 in Table 2), 
the highest match with the library data was for 
pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-
(2-methylpropyl)-. Clearly, those peaks should 
represent four different compounds. We could 
suppose that pyrrolo[1,2-a]pyrazine-1,4-dione, 
hexahydro-3-(2-methylpropyl)- corresponds to the 
compound with RT 50.19 min (Table 2, compound 
No. 10), as its mass spectrum shows the highest 
match with the library data. Other three peaks 
should correspond to the compounds with very 
similar structure, as their mass spectra are quite 
similar with a very intense fragment peak at 
m/z 154 that could be attributed to hexahydro 
pyrrolo[1,2-a]pyrazine-1,4-dione (molecular mass 
154). When harsh electron ionization is applied, the 
compounds undergo fragmentation and their molecular 
ions are not intense. Two of the compounds (with RT 
49.58 and 50.19 min – Table 2, compounds No. 9 
and 10 respectively) have the same molecular ion 
with m/z 210 indicating that they could be isomers 
of pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-
(2-methylpropyl)-. A compound eluting at 46.23 
min (Table 2, compound No. 8) has a molecular 
ion of m/z 196 and probably could be identified 
as pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-
(2-isopropyl)-. A compound eluting at 58.70 min 
(Table 2, compound No. 11) has a low intensity 
molecular ion peak at m/z 343. Unfortunately, 
very few mass spectra of related compounds can be 
found in the library, thus more precise identification 
was not possible. It should be noted that 
pyrrolopyrazines pyrrolo[1,2-a]pyrazine-1,4-dione, 
hexahydro-3-(2-methylpropyl)- and pyrrolo[1,2-a]
pyrazine-1,4-dione, hexahydro-3-(phenylmethyl)- 
are semivolatile cyclic dipeptides also called cyclo 
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Fig. 4. Thin layer chromatography and bioautography of chloroform 
extracts. Micrococcus luteus was used for bioautography as the 
test microorganism. Both 1350R2-TSA30-6 and 1410WF1-TSA30-2 
showed two different fractions on TLC plates, but only a single fraction 
of each strain showed antimicrobial activity.
(L-leucyl-L-prolyl) (or 2,5-diketopiperazine antibiotic 
gancidin W) and cyclo(L-prolyl-D-phenylalanyl) 
respectively.
Nineteen main compounds with the content of 
≥0.5% were identified in active fraction of the strain 
1410WF1-TSA30-2 (Table 3). The set of volatile 
compounds differed for both strains, the only 
common compound was 1,2-benzenedicarboxylic 
acid, diisooctyl ester (Table 2, compound No. 13; 
Table 3, compound No. 19). It should be noted, that only 
some of the identified constituents of active fractions 
were volatiles previously identified in other bacteria 
(Tables 2, 3). 
Spectrum of inhibitory activity  
of antimicrobial compounds
The active TLC fractions of strains 1350R2-
TSA30-6 and 1410WF1-TSA30-2 were evaluated for 
their antimicrobial activity against Gram-positive 
pathogenic bacteria as well as against bacteria 
isolated from Krubera-Voronja Cave. 
The highest activity of active TLC fraction of the 
strain 1350R2-TSA30-6 was observed against R. equi 
ATCC 6939, while the lowest activity was recorded 
against S. aureus subsp. aureus ATCC 25923 and 
B. cereus ATCC 10876 (Table 4). The concentration 
0.291 mg/mL was still inhibitory for all tested 
pathogenic strains, except for S. aureus subsp. 
aureus ATCC 25923. The MIC for the strain of S. 
aureus subsp. aureus was 0.583 mg/mL, while for 
Pathogen
The concentration of the antimicrobial compounds  
in ethyl acetate, mg/mL
4.660 2.330 1.165 0.583 0.291 0.146
Bacillus cereus ATCC 10876 6.5 6.0 5.0 3.0 2.0 0
Enterococcus faecalis ATCC 29212 10.0 7.0 5.0 4.0 2.0 0
Listeria monocytogenes ATCC 7644 7.0 6.5 5.0 3.5 3.0 0
Staphylococcus aureus subsp. aureus ATCC 25923 3.5 1.5 0.5 0.5 0 0
Rhodococcus equi ATCC 6939 12.0 8.0 5.5 5.0 3.0 0
Table 4. Antibacterial activity of the active TLC fraction of strain 1350R2-TSA30-6 against pathogenic bacteria. The width of the inhibition 
zone is shown in millimeters.
other four pathogenic strains it was 0.291 mg/mL 
(Table 4). It should be noted, that the active TLC fraction 
was the only partially purified mixture of compounds, 
therefore, the inhibitory concentrations could not be 
evaluated for the discrete active compounds. 
Antibacterial compounds of the strain 1350R2-
TSA30-6 also inhibited growth of other bacteria of 
Krubera-Voronja Cave: Streptomyces sp. 1350R2-
SCNA30, Brevibacillus sp. 1410WF1-HT30-5, and 
Paenibacillus sp. 23TSA30-6 (Fig. 5). 
The active fraction of strain 1410WF1-TSA30-2 
showed no antimicrobial activity against the tested 
pathogenic bacteria. But antimicrobial compounds of 
this strain had inhibitory effect on the growth of other 
bacteria isolated from Krubera-Voronja Cave (Fig. 5). 
Only Streptomyces sp. 1350R2-SCNA30 was resistant 
to antibacterial compounds produced by the strain 
1410WF1-TSA30-2. 
DISCUSSION
For isolation of microorganisms from Krubera-
Voronja Cave, general purpose media (TSA) as well 
as the growth media designed for the isolation and 
cultivation of actinobacteria (HT agar, AI agar, SCNA, 
ISP4) were used. The choice of the latter four media 
was based on the well-known antimicrobial activity 
of the members of phylum Actinobacteria (Rule & 
Cheeptham, 2013). Nevertheless, the percentage 
(14.0%) of Krubera-Voronja Cave isolates, that 
produce antimicrobial compounds, was quite low and 
comparable to some shallow caves: Backcountry Cave 
(6 m in depth), Spider Cave (44 m in depth), and Fort 
Stanton Cave (134 m in depth) – 21.1%, 19.8% and 
8.6% respectively (Montano & Henderson, 2013). On 
the other hand, data for some other shallow caves 
show higher percentage of active isolates than of 
Krubera-Voronja Cave: 66% for the Left Hand Tunnel 
passage in Carlsbad Cavern (316 m in depth), 40% 
for Lechuguilla Cave (489 m in depth) (Montano & 
Henderson, 2013), 57% for Helmckens Falls Cave 
(Rule & Cheeptham, 2013), 73.9% for Magura Cave 
(56 m in depth) (Tomova et al., 2013). Our results 
also showed that the percentage of bacteria capable of 
antagonistic activity increased from the upper to the 
lower part of the cave. These results were in accordance 
with the findings of Montano & Henderson (2013) 
who revealed that the increasing depth influenced the 
antimicrobial activity of the cave isolates. To the best 
of our knowledge, our present study is the first report 
on the antimicrobial activity of bacterial isolates in 
Krubera-Voronja Cave. 
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The other focus of our research was the antibacterial 
activity targeting Gram-positive bacteria. It should be 
noted that Gram-positive pathogens are a major cause 
of nosocomial bacterial infections. Staphylococci, 
enterococci, streptococci, and Clostridium difficile 
are the most important species of clinical interest 
(Rossolini et al., 2014). Antibiotic resistance issues 
are common among Gram-positive pathogens, and 
the percentage of nosocomial infections caused 
by antibiotic-resistant Gram-positive bacteria is 
increasing. For example, in the United States, 
approximately 60% of staphylococcal infections are 
now caused by multidrug-resistant S. aureus, and 
these percentages continue to rise (Rice, 2006). 
Therefore, the development of novel antibiotics that 
would be active against Gram-positive pathogens 
is imperative. Only a small portion (24 out of 874) 
of bioactive isolates were antagonistic exclusively 
against Gram-positive bacteria, moreover – the 
bioactivity of the most of these 24 isolates was very 
weak. Two most active strains 1350R2-TSA30-6 and 
1410WF1-TSA30-2, isolated from the lower part of 
the cave, were chosen for detailed characterization of 
the antimicrobials. It is of interest that these strains, 
although antagonistic against Gram-positive test 
strains M. luteus and B. thuringiensis TL8, were also 
Gram-positive - both strains were assigned to the 
genus Bacillus. 
Bacteria of the family Bacillaceae are mainly known 
for their antimicrobial peptides – both ribosomally 
and nonribosomally synthesized peptide antibiotics. 
Nonribosomally synthesized antibiotic bacitracin A 
is produced by Bacillus licheniformis, lipopeptides 
surfactin, iturin, bacillomycin, and fengycin are 
produced by several strains of Bacillus subtilis. 
Well-known ribosomally synthesized peptides 
(bacteriocins) of Bacillaceae include subtilin and 
subtilosin A from B. subtilis; coagulin from Bacillus 
coagulans; bacthuricin F4, thuricin 17, entomocin 
9, and tochicin from B. thuringiensis; cerecin 7 
from B. cereus; bacillocin 490 from B. licheniformis 
(Sumi et al., 2015). On the other hand, bacilli also 
produce non-peptide antimicrobial compounds, 
such as bis (2-ethylhexyl) phthalate, synthesized by 
Bacillus pumilus (Moushumi Priya & Jayachandran, 
Fig. 5. Antibacterial activity of active TLC fractions against bacteria isolated from Krubera-
Voronja Cave. The concentration of antimicrobial compounds in ethyl acetate was 1.165 
mg/mL. 1 – Streptomyces sp. 1350R2-SCNA30; 2 – Brevibacillus sp. 1410WF1-HT30-5; 
3 – Gram-positive strain 28TSA30-8; 4 – Paenibacillus sp. 28ISP30-5; 5 – Paenibacillus 
sp. 23TSA30-6.
2012); macrolide antibiotics macrolactins 1-3 
produced by Bacillus sp. (Mondol et al., 2011); 
macrolides gageomacrolactins 1-3 produced 
by B. subtilis (Tareq et al., 2013). Therefore, 
production of both antimicrobial peptides 
and non-peptide antibiotics was expected for 
bioactive strains from Krubera-Voronja Cave.
The antimicrobials of strains 1350R2-
TSA30-6 and 1410WF1-TSA30-2 differed 
significantly. The active compounds behaved 
differently in some organic solvents during 
extraction as well as had different Rf values 
in TLC. It was also noticed that antimicrobial 
substances of the strain 1350R2-TSA30-6 
were stable, and the inhibition zone was 
visible constantly during the growth of 
the test microorganism in bioautography 
experiments, while antimicrobial substances 
of the strain 1410WF1-TSA30-2 inhibited the test 
microorganism only at the first stages of its growth, 
but disappeared through further cultivation due to 
evaporation of active compounds or their inactivation 
by the growing culture of M. luteus (data not shown). 
Activity of antimicrobials of the strain 1350R2-
TSA30-6 was higher than of strain 1410WF1-TSA30-2. 
The common characteristics for both strains included 
poor production of antimicrobials in a highly rich 
growth medium BHIB as well as continued production 
of active compounds during the growth of the culture 
starting in the exponential growth phase. The first 
characteristic can be associated with the need to 
produce antimicrobials under starvation, but not 
under the nutrient-rich growth conditions (Montano 
& Henderson, 2013). The second feature (the time of 
production) indicated that antimicrobial compounds 
(or at least some of them) were primary metabolites 
(Sanchez & Demain, 2008). 
Chemical compounds in the active TLC fractions 
of both strains differed markedly. The main 
antibacterial agents of the strain 1350R2-TSA30-6 
were 2,5-diketopiperazine antibiotics. Most of 
2,5-diketopiperazines are stable to proteolysis (Pérez-
Picaso et al., 2009), and we have also observed this 
effect after treatment of the salted-out extracellular 
proteins of the strain 1350R2-TSA30-6 with proteinase 
K. Antitumor, antifungal, antiviral, and antibacterial 
activities of cyclic dipeptides are well-known (Yan 
et al., 2004; Pandey et al., 2010; de Carvalho & 
Abraham, 2012; Kumar et al., 2014). Cyclic dipeptides 
are usually produced by Gram-negative bacteria, but 
have been also isolated from Gram-positive. Among 
the genera of the family Bacillaceae, they were so 
far identified only in the genus Bacillus (de Carvalho 
& Abraham, 2012; Leyton et al., 2012). Because of 
their activity spectrum, cyclic dipeptides attract much 
attention as potential pharmaceuticals. Our results 
clearly showed that antibacterial fraction of the 
strain 1350R2-TSA30-6 was active against Gram-
positive pathogenic bacteria B. cereus, E. faecalis, L. 
monocytogenes, S. aureus subsp. aureus, and R. equi. 
Cyclic dipeptides are secondary metabolites (Leyton 
et al., 2012), therefore, if they would be the only 
compounds with bioactivity, then the antimicrobial 
284 Klusaite et al.
International Journal of Speleology, 45 (3), 275-287. Tampa, FL (USA) September 2016 
effect would appear only in the stationary phase 
of the culture growth. But antimicrobial activity 
was also detected in the exponential growth phase 
of the strain 1350R2-TSA30-6. We have concluded that 
other volatile compounds, identified in an active fraction 
of this strain, were responsible for this early effect. For 
example, antibacterial, antiviral, or antifungal activities 
were previously reported for 1,2-benzenedicarboxylic 
acid, diisooctyl ester (Rameshthangam & Ramasamy, 
2007; Maruthupandian & Mohan, 2011) and 
1,3-dimethyl-benzene (El-Shouny et al., 2014). Some 
compounds (ethylbenzene, p-xylene) were previously 
identified in mixtures of bacterial volatiles (Tenorio-
Salgado et al., 2013), while others (cyclohexanone) 
- in plant extracts (Kim et al., 2011) possessing 
antimicrobial activity. 
GC-MS results for the strain 1410WF1-TSA30-2 
markedly differed from the results for strain 1350R2-
TSA30-6. The only common antimicrobial compound 
was 1,2-benzenedicarboxylic acid, diisooctyl ester. 
Cyclic dipeptides were not found, but a range of other 
compounds with different bioactivities were identified. 
Antibacterial, antiviral, antifungal, or antioxidant 
activities were previously reported for dibutyl phthalate 
(Maruthupandian & Mohan, 2011), nonadecane 
(Fernando et al., 2005), phenol, 2,4-bis(1,1-
dimethylethyl)- (Varsha et al., 2015). Some compounds 
(hexadecane, octadecane) were previously identified 
in antimicrobial or nematicidal mixtures of bacterial 
volatiles (Gu et al., 2007; Karanja et al., 2010), while 
others (1-nonadecene, 2-methyl-eicosane) - in plant 
extracts with antibacterial activity (Boussaada et al., 
2008). The main compounds in antibacterial mixture of 
volatiles of the strain 1410WF1-TSA30-2 were benzoic 
acid, octadecyl ester and 1,2-benzenedicarboxylic 
acid, bis(2-methylpropyl) ester. We could not find any 
information about putative antimicrobial activity of 
octadecyl benzoate; it was not listed among bacterial 
volatiles in the mVOC and SuperScent databases either. 
But the esters of 1,2-benzenedicarboxylic acid (bis(2-
ethylhexyl) ester, bis(2-methylpropyl) ester, butyl-2-
methylpropyl ester, butyl-2-ethylhexyl ester, diisooctyl 
ester, etc.) are frequently the main components of 
antibacterial and antifungal mixtures of volatiles from 
different sources: algae (Sivakumar, 2014), plants 
(Joshi et al., 2011), fungi (Nakalembe & Kabasa, 2012), 
bacteria (El-Mehalawy et al., 2008). Actually these esters 
are believed to be responsible for antimicrobial activity 
of these mixtures of volatiles. Antiviral, antifungal, 
and antibacterial activities were demonstrated for 
1,2-benzenedicarboxylic acid, bis(2-ethylhexyl) ester; 
while antimicrobial, antioxidant, and antitumor 
activities were shown for 1,2-benzenedicarboxylic 
acid, mono(2-ethylhexyl) ester (Kavitha et al., 2009; 
Karthikeyan et al., 2014). Antibacterial and antifungal 
activities were confirmed for 1,2-benzenedicarboxylic 
acid, bis(5-ethylheptyl) ester (Kavitha et al., 2009). 
1,2-benzenedicarboxylic acid, bis(2-methylpropyl) 
ester, found in active antibacterial fraction of the strain 
1410WF1-TSA30-2, had been also identified in a few 
other representatives of the genus Bacillus (Hao & Lu, 
2007; Mallaiah & Muthamilan, 2015). 
It is known that bacteria use volatile metabolites for 
inter- and intraspecific communications as well as in 
order to respond and adapt to environmental changes 
(Audrain et al., 2015). Microorganisms in caves form 
multispecies communities with complex interaction 
networks among their members, and bacterial volatile 
mixtures can participate in these interactions. For 
example, it had been previously shown that Bacillus 
sp. can start producing cyclic dipeptides when 
challenged by a co-culture of other Bacillus species 
(de Carvalho & Abraham, 2012). Our results showed 
that antimicrobial volatile mixtures of strains 1350R2-
TSA30-6 and 1410WF1-TSA30-2 could be also involved 
in the competition and engagement with other bacterial 
species in Krubera-Voronja Cave. The strains of Gram-
positive genera Paenibacillus and Brevibacillus (phylum 
Firmicutes, family Paenibacillaceae) were sensitive to 
active antimicrobial fractions of both strains isolated 
from the same cave. The main difference between 
volatiles of both investigated strains was in their 
antagonism against actinobacterial strain of the genus 
Streptomyces. It is interesting that antimicrobial 
compounds of the strain 1410WF1-TSA30-2 were 
antagonistic against bigger number of cave strains 
than antimicrobial compounds of the strain 1350R2-
TSA30-6. This is contrary to the zero antimicrobial 
activity of volatiles of the strain 1410WF1-TSA30-2 
against pathogenic bacteria. It was supposed that 
the primary role of volatiles of the strain 1410WF1-
TSA30-2 is the competition with the indigenous Gram-
positive microorganisms of the cave. 
In conclusion, our results clearly demonstrated 
that while screening for novel bioactive compounds, 
examining the lesser-studied phyla, such as Firmicutes, 
rather than the commonly examined Actinobacteria 
is an important and promising approach. Cave 
actinobacteria are usually the main targets of 
bioactivity assays, and therefore the antimicrobial 
potential of other bacteria is underestimated. Detailed 
analysis of two Firmicutes strains, isolated from 
Krubera-Voronja Cave, revealed two different mixtures 
of compounds with antibacterial activity. The main 
antibacterial compounds of the strain 1350R2-TSA30-6 
were pyrrolopyrazines, and the main antibacterial 
compound of the strain 1410WF1-TSA30-2 was bis(2-
methylpropyl) ester of 1,2-benzenedicarboxylic acid. 
To the best of our knowledge, our study is the first 
report on chemical characterization of antimicrobial 
mixtures of Firmicutes isolated from caves.
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